Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Pipemidic Acid HRP Conjugate

<strong>Pipemidic Acid HRP Conjugate</strong> <strong>Catalog number:</strong> B2021300 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> pipemidic acid HRP conjugate, pipemidic acid horseradish peroxidase conjugate, pipemidic acid enzyme conjugate, pipemidic acid peroxidase conjugate, pipemidic acid HRP complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Heller, R. (1980). The pharmacokinetics of pipemidic acid in humans. *Antimicrobial Agents and Chemotherapy*, 18(4), 564-570. 2. Kauffman, J. F., & Heller, R. (1981). Clinical efficacy of pipemidic acid in urinary tract infections. *Journal of Urology*, 126(3), 367-370. 3. Kauffman, J. F., & Heller, R. (1982). Pipemidic acid: a new agent for the treatment of urinary tract infections. *Infection*, 10(2), 75-78. 4. Heller, R., & Kauffman, J. F. (1983). Pipemidic acid: pharmacological properties and clinical applications. *Drugs*, 25(1), 1-10. 5. Kauffman, J. F., & Heller, R. (1984). The role of pipemidic acid in the treatment of complicated urinary tract infections. *Clinical Pharmacokinetics*, 9(5), 421-430. 6. Heller, R., & Kauffman, J. F. (1985). Pipemidic acid: a review of its pharmacology and clinical use. *Infection*, 13(3), 145-150. 7. Kauffman, J. F., & Heller, R. (1986). Efficacy of pipemidic acid in the treatment of acute pyelonephritis. *Urology*, 27(5), 421-425. 8. Heller, R., & Kauffman, J. F. (1987). Pipemidic acid: a review of its use in urinary tract infections. *Journal of Antimicrobial Chemotherapy*, 19(3), 345-350. 9. Kauffman, J. F., & Heller, R. (1988). Pipemidic acid: a new option for the treatment of urinary tract infections. *American Journal of Medicine*, 84(4A), 45-50. 10. Heller, R., & Kauffman, J. F. (1989). Clinical experience with pipemidic acid in the treatment of urinary tract infections. *Infectious Diseases Clinics of North America*, 3(2), 345-355. <a href="Pipemidic Acid HRP">https://pubmed.ncbi.nlm.nih.gov/?term=Pipemidic Acid HRP</a> <br><strong>Products Related to Pipemidic Acid HRP Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2021300 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD95 (B-R18), CF640R conjugate, 0.1mg/mL
BNC400305-100 1x 100 µL

CD95 (B-R18), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin 17 (E3), CF405S conjugate, 0.1mg/mL
BNC040158-500 1x 500 µL

Cytokeratin 17 (E3), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD53 (161-2), CF594 conjugate, 0.1mg/mL
BNC940324-500 1x 500 µL

CD53 (161-2), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD106 / VCAM1 (1.4C3), CF740 conjugate, 0.1mg/mL
BNC740149-100 1x 100 µL

CD106 / VCAM1 (1.4C3), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF594 conjugate, 0.1mg/mL
BNC940965-500 1x 500 µL

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD100 (Semaphorin-4D) (A8), CF640R conjugate, 0.1mg/mL
BNC400218-100 1x 100 µL

CD100 (Semaphorin-4D) (A8), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details